• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Ulthera

Anonymous board for Ulthera
Replies
3
Views
4K
anonymous
Replies
5
Views
9K
Anonymous
Replies
1
Views
4K
Anonymous